Onconetix, Inc. (ONCO)

Every figure this model derived for ONCO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2024-12-31
cash 5,942,249 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 6,517,810 AssetsCurrent 2026-06-30
current liabilities 2,943,793 LiabilitiesCurrent 2026-06-30
equity 13,468,509 StockholdersEquity 2026-06-30
interest expense 310,949 InterestExpenseNonoperating 2026-06-30
ocf -10,307,962 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 645,824 Revenues 2026-06-30
sbc 43,693 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ONCO on one particular measure came for.

RatioValue
current ratio2.21
current ratio reported2.21
dilution pct2809.68
fcf margin-1596.09
interest cover-52.44
owner earnings margin-1602.86
revenue growth-51.33
revenue growth per share-98.33
roic-167.82
rule of 40-2576.35
sbc pct revenue6.77

What to be careful about

What this model itself distrusts about ONCO's figures. Written by the derivation as it ran, not added afterwards.